Neurological
Cancer

Oncology Solutions

The Patient Journey


In the United States, about 23,820 malignant tumors of the brain or spinal cord will be diagnosed in 2019.1 With the technological advances in the technology field, brain tumor imaging has become an essential component in managing the patients across the care pathway.

  • SIGNA™ Architect AIR™ Edition

    Our premium 3.0T, 70 cm wide bore MRI system leverages intelligent technology to enable patient-friendly exams with exceptional image quality.
  • SIGNA™ Premier AIR™ IQ Edition

    Our leading, innovative 3.0T MRI system brings you uncompromised 60 cm performance in a 70 cm wide bore for advanced imaging and research.
  • SIGNA™ PETMR with QuantWorks

    Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.
  • SIGNA™ PETMR with QuantWorks

    Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

The latest in Oncology


1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html

JB04823XX